Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study - Gainor, Justin; Curigliano, Giuseppe; Kim, Dong-Wan; Lee, Dae Ho; Besse, Benjamin; Baik, Christina S.; Doebele, Robert C.; Cassier, Philippe A.; Lopes, Gilberto; Tan, Daniel S.-W.; Garralda, Elena; Paz-Ares, Luis G.; et al. (The lancet. Oncology, 2021)
Gesehen am 22.09.2021